MicroRNAs Association in the Cardiac Hypertrophy Secondary to Complex Congenital Heart Disease in Children
- PMID: 28382463
- DOI: 10.1007/s00246-017-1607-8
MicroRNAs Association in the Cardiac Hypertrophy Secondary to Complex Congenital Heart Disease in Children
Abstract
Complex congenital heart disease (CHD) affects cardiac blood flow, generating a pressure overload in the compromised ventricles and provoking hypertrophy that over time will induce myocardial dysfunction and cause a potential risk of imminent death. Therefore, the early diagnosis of complex CHD is paramount during the first year of life, with surgical treatment of patients favoring survival. In the present study, we analyzed cardiac tissue and plasma of children with cardiac hypertrophy (CH) secondary to CHD for the expression of 11 miRNAs specific to CH in adults. The results were compared with the miRNA expression patterns in tissue and blood of healthy children. In this way, we determined that miRNAs 1, 18b, 21, 23b, 133a, 195, and 208b constitute the expression profile of the cardiac tissue of children with CHD. Meanwhile, miRNAs 21, 23a, 23b, and 24 can be considered specific biomarkers for the diagnosis of CH in infants with CHD. These results suggest that CH secondary to CHD in children differs in its mechanism from that described for adult hypertrophy, offering a new perspective to study the development of this pathology and to determine the potential of hypertrophic miRNAs to be biomarkers for early CH.
Keywords: Cardiac hypertrophy; Children; Complex congenital heart; MicroRNAs.
Similar articles
-
Clinical significance of circulating microRNAs as markers in detecting and predicting congenital heart defects in children.J Transl Med. 2018 Feb 27;16(1):42. doi: 10.1186/s12967-018-1411-0. J Transl Med. 2018. PMID: 29482591 Free PMC article.
-
Identification of microRNAs present in congenital heart disease associated copy number variants.Eur Rev Med Pharmacol Sci. 2013;17(15):2114-20. Eur Rev Med Pharmacol Sci. 2013. PMID: 23884835
-
Cardiac biomarkers in children with congenital heart disease.World J Pediatr. 2015 Nov;11(4):309-15. doi: 10.1007/s12519-015-0039-x. Epub 2015 Oct 11. World J Pediatr. 2015. PMID: 26454435 Review.
-
Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.J Mol Cell Cardiol. 2015 Apr;81:1-9. doi: 10.1016/j.yjmcc.2015.01.008. Epub 2015 Jan 26. J Mol Cell Cardiol. 2015. PMID: 25633833
-
MicroRNAs in a hypertrophic heart: from foetal life to adulthood.Biol Rev Camb Philos Soc. 2017 Aug;92(3):1314-1331. doi: 10.1111/brv.12283. Epub 2016 Jun 1. Biol Rev Camb Philos Soc. 2017. PMID: 27247253 Review.
Cited by
-
Role of miRNA in Cardiovascular Diseases in Children-Systematic Review.Int J Mol Sci. 2024 Jan 12;25(2):956. doi: 10.3390/ijms25020956. Int J Mol Sci. 2024. PMID: 38256030 Free PMC article.
-
Understanding the Impact of Perfluorinated Compounds on Cardiovascular Diseases and Their Risk Factors: A Meta-Analysis Study.Int J Environ Res Public Health. 2021 Aug 6;18(16):8345. doi: 10.3390/ijerph18168345. Int J Environ Res Public Health. 2021. PMID: 34444092 Free PMC article. Review.
-
Advances in Cardiovascular Biomarker Discovery.Biomedicines. 2020 Nov 30;8(12):552. doi: 10.3390/biomedicines8120552. Biomedicines. 2020. PMID: 33265898 Free PMC article. Review.
-
MicroRNAs in chronic pediatric diseases (Review).Exp Ther Med. 2024 Jan 15;27(3):100. doi: 10.3892/etm.2024.12388. eCollection 2024 Mar. Exp Ther Med. 2024. PMID: 38356668 Free PMC article. Review.
-
Characterisation of the developing heart in a pressure overloaded model utilising RNA sequencing to direct functional analysis.J Anat. 2020 Mar;236(3):549-563. doi: 10.1111/joa.13112. Epub 2019 Nov 14. J Anat. 2020. PMID: 31724174 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical